ABOUT THE PRODUCT
RIV-5061 is a novel small molecule drug candidate under development by Revivo Therapeutics for the treatment of Mild Cognitive Impairment (MCI) and other forms of cognitive decline. It targets [specific mechanism - details to be added upon further research].
Information is owner-confirmed
Last updated 5 months ago
Price range